Recomendaciones para el uso correcto de densitometría ósea en la práctica clínica. Consenso de la Sociedad Chilena de Endocrinología y Diabetes

Barberan M, Marcela; Campusano, Claudia; Patricio Trincado M.; Oviedo G, Sofia; Brantes G, Sergio; Jorge Sapunar Z.; Canessa G, José; Cid R, María Pía; Escobar L, Freddy; Eugenin, D; Florenzano P.; Gajardo H. I.; Gonzalez G.; Velasco, S.


Osteoporosis is a silent and frequent disease, which increases fracture risk. Approximately half of women and one of five men over 50 years old will suffer an osteoporotic fracture throughout their lives. Dual-energy x-ray absorptiometry (DXA) allows a real bone mineral density (BMD) measurement in different parts of the skeleton and is considered the “gold standard” for quantifying osteoporosis with high accuracy and precision. The Board of the Chilean Society of Endocrinology and Diabetes (SOCHED) required from the Bone Disease Study Group to develop a consensus about the “Correct use of bone densitometry in clinical practice in Chilean population”. Therefore, we elaborated 25 questions which addressed key aspects about the indications for a DXA scan, and the details of how to perform and report this test. Since some of the evidence obtained was of low quality or inconclusive, we decided to create a multidisciplinary group of national experts in osteoporosis to develop a consensus in this subject. The group consisted of 22 physicians including endocrinologists, gynecologists, geriatricians, radiologists, rheumatologists and nuclear medicine specialists. Using the Delphi methodology to analyze previously agreed questions, we elaborated statements that were evaluated by the experts who expressed their degree of agreement. The final report of this consensus was approved by the SOCHED board.

Más información

Título de la Revista: REVISTA MEDICA DE CHILE
Volumen: 146
Editorial: Sociedad Médica de Santiago
Fecha de publicación: 2018
Página de inicio: 1471
Página final: 1480
Idioma: español
Financiamiento/Sponsor: SOCHED

pubmed, scielo